| Stage | RSG | % of rev | HLT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.6B | 100.00% | $3.3B | 100.00% | RSG ×1.37 |
| Gross profit | $1.9B | 41.59% | $3.1B | 91.85% | HLT +50.3pp |
| Operating income | $921M | 20.20% | $909M | 27.34% | HLT +7.1pp |
| Pre-tax income | $719M | 15.77% | $722M | 21.71% | HLT +5.9pp |
| Net income | $593M | 13.01% | $536M | 16.12% | HLT +3.1pp |
| Stage | RSG | HLT | Gap · A − B |
|---|---|---|---|
| Revenue | $4.6B100.00% | $3.3B100.00% | RSG ×1.37 |
| Gross profit | 41.59%$1.9B | 91.85%$3.1B | HLT +50.3pp |
| Operating income | 20.20%$921M | 27.34%$909M | HLT +7.1pp |
| Pre-tax income | 15.77%$719M | 21.71%$722M | HLT +5.9pp |
| Net income |
| 13.01%$593M |
| 16.12%$536M |
| HLT +3.1pp |
No shared counterparties.